Key representative bodies in the UK medicines supply and distribution sector have recently reached an important stage in ensuring the continued safety of patients across the UK.Read more
In the lead up to our Annual Conference 2015, Mark Flannagan, Chief Executive of Beating Bowel Cancer, reminds us of the massive benefits the Cancer Drugs Fund delivers and explains why, five years on, changes must be made to ensure patients are able to access medicines that can extend and improve their lives.Read more
This week’s warning from the National Risk Register of Civil Emergencies that “[u]ntreatable superbugs that have evolved to be resistant to drugs could kill up to 80,000 people in a single outbreak…”1 highlights a message that the pharmaceutical industry has been making for years now – antimicrobial resistance is a critical and emerging public health threat and we urgently need new medicines and approaches to address this.Read more
The ABPI’s Dr Virginia Acha says ‘the interests of the patient are paramount’ following the BMJ’s call for NHS doctors to be able to routinely prescribe an unlicensed medicine for the treatment of wet age related macular degeneration.Read more
Our website is not compatible with Internet Explorer 8. If you are experiencing problems with scrolling please upgrade to a later version or use another browser.